-
1
-
-
77958498224
-
Vaccine adjuvants: Putting innate immunity to work
-
Coffman, R. L. , A. Sher, and R. A. Seder. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity 33: 492-503.
-
(2010)
Immunity
, vol.33
, pp. 492-503
-
-
Coffman, R.L.1
Sher, A.2
Seder, R.A.3
-
2
-
-
79955086319
-
Recent clinical experience with vaccines using MPL-and QS-21?containing adjuvant systems
-
Garçon, N. , and M. Van Mechelen. 2011. Recent clinical experience with vaccines using MPL-and QS-21?containing adjuvant systems. Expert Rev. Vaccines 10: 471-486.
-
(2011)
Expert Rev. Vaccines
, vol.10
, pp. 471-486
-
-
Garçon, N.1
Van Mechelen, M.2
-
3
-
-
78650430146
-
Combination adjuvants: The next generation of adjuvants?
-
Mutwiri, G. , V. Gerdts, S. van Drunen Littel-van den Hurk, G. Auray, N. Eng, S. Garlapati, L. A. Babiuk, and A. Potter. 2011. Combination adjuvants: the next generation of adjuvants? Expert Rev. Vaccines 10: 95-107.
-
(2011)
Expert Rev. Vaccines
, vol.10
, pp. 95-107
-
-
Mutwiri, G.1
Gerdts, V.2
Van Drunen Littel-Van Den Hurk, S.3
Auray, G.4
Eng, N.5
Garlapati, S.6
Babiuk, L.A.7
Potter, A.8
-
4
-
-
64049085035
-
Mechanism of action of clinically approved adjuvants
-
Lambrecht, B. N. , M. Kool, M. A. Willart, and H. Hammad. 2009. Mechanism of action of clinically approved adjuvants. Curr. Opin. Immunol. 21: 23-29.
-
(2009)
Curr. Opin. Immunol
, vol.21
, pp. 23-29
-
-
Lambrecht, B.N.1
Kool, M.2
Willart, M.A.3
Hammad, H.4
-
5
-
-
42249088234
-
Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
-
Kool, M. , T. Soullié, M. van Nimwegen, M. A. Willart, F. Muskens, S. Jung, H. C. Hoogsteden, H. Hammad, and B. N. Lambrecht. 2008. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J. Exp. Med. 205: 869-882.
-
(2008)
J. Exp. Med
, vol.205
, pp. 869-882
-
-
Kool, M.1
Soullié, T.2
Van Nimwegen, M.3
Willart, M.A.4
Muskens, F.5
Jung, S.6
Hoogsteden, H.C.7
Hammad, H.8
Lambrecht, B.N.9
-
6
-
-
79955079057
-
Monophosphoryl lipid A and synthetic lipid A mimetics in TLR4-based adjuvants and immunomodulators
-
C. J. Hackett, and D. A. Harn, Jr. , eds. Humana Press Inc. , Totowa, NJ
-
Baldridge, J. R. , K. Myers, D. Johnson, D. Persing, C. Cluff, and R. Hershberg. 2008. Monophosphoryl lipid A and synthetic lipid A mimetics in TLR4-based adjuvants and immunomodulators. In Vaccine Adjuvants: Immunological and Clinical Principles. C. J. Hackett, and D. A. Harn, Jr. , eds. Humana Press Inc. , Totowa, NJ, p. 235-255.
-
(2008)
Vaccine Adjuvants: Immunological and Clinical Principles
, pp. 235-255
-
-
Baldridge, J.R.1
Myers, K.2
Johnson, D.3
Persing, D.4
Cluff, C.5
Hershberg, R.6
-
7
-
-
0034048453
-
The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells
-
De Becker, G. , V. Moulin, B. Pajak, C. Bruck, M. Francotte, C. Thiriart, J. Urbain, and M. Moser. 2000. The adjuvant monophosphoryl lipid A increases the function of antigen-presenting cells. Int. Immunol. 12: 807-815.
-
(2000)
Int. Immunol
, vol.12
, pp. 807-815
-
-
De Becker, G.1
Moulin, V.2
Pajak, B.3
Bruck, C.4
Francotte, M.5
Thiriart, C.6
Urbain, J.7
Moser, M.8
-
8
-
-
77249176352
-
AS04, an aluminum salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity
-
Didierlaurent, A. M. , S. Morel, L. Lockman, S. L. Giannini, M. Bisteau, H. Carlsen, A. Kielland, O. Vosters, N. Vanderheyde, F. Schiavetti, et al. 2009. AS04, an aluminum salt-and TLR4 agonist-based adjuvant system, induces a transient localized innate immune response leading to enhanced adaptive immunity. J. Immunol. 183: 6186-6197.
-
(2009)
J. Immunol
, vol.183
, pp. 6186-6197
-
-
Didierlaurent, A.M.1
Morel, S.2
Lockman, L.3
Giannini, S.L.4
Bisteau, M.5
Carlsen, H.6
Kielland, A.7
Vosters, O.8
Vanderheyde, N.9
Schiavetti, F.10
-
9
-
-
0037080353
-
Monophosphoryl lipid A activates both human dendritic cells and T cells
-
Ismaili, J. , J. Rennesson, E. Aksoy, J. Vekemans, B. Vincart, Z. Amraoui, F. Van Laethem, M. Goldman, and P. M. Dubois. 2002. Monophosphoryl lipid A activates both human dendritic cells and T cells. J. Immunol. 168: 926-932.
-
(2002)
J. Immunol
, vol.168
, pp. 926-932
-
-
Ismaili, J.1
Rennesson, J.2
Aksoy, E.3
Vekemans, J.4
Vincart, B.5
Amraoui, Z.6
Van Laethem, F.7
Goldman, M.8
Dubois, P.M.9
-
10
-
-
0026033441
-
Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex
-
Kensil, C. R. , U. Patel, M. Lennick, and D. Marciani. 1991. Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. J. Immunol. 146: 431-437.
-
(1991)
J. Immunol
, vol.146
, pp. 431-437
-
-
Kensil, C.R.1
Patel, U.2
Lennick, M.3
Marciani, D.4
-
11
-
-
79955112512
-
Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer
-
Ragupathi, G. , J. R. Gardner, P. O. Livingston, and D. Y. Gin. 2011. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer. Expert Rev. Vaccines 10: 463-470.
-
(2011)
Expert Rev. Vaccines
, vol.10
, pp. 463-470
-
-
Ragupathi, G.1
Gardner, J.R.2
Livingston, P.O.3
Gin, D.Y.4
-
12
-
-
0031661414
-
QS-21: A water-soluble triterpene glycoside adjuvant
-
Kensil, C. R. , and R. Kammer. 1998. QS-21: a water-soluble triterpene glycoside adjuvant. Expert Opin. Investig. Drugs 7: 1475-1482.
-
(1998)
Expert Opin. Investig. Drugs
, vol.7
, pp. 1475-1482
-
-
Kensil, C.R.1
Kammer, R.2
-
13
-
-
0028800377
-
Structure/function studies of QS-21 adjuvant: Assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function
-
Soltysik, S. , J. Y. Wu, J. Recchia, D. A. Wheeler, M. J. Newman, R. T. Coughlin, and C. R. Kensil. 1995. Structure/function studies of QS-21 adjuvant: assessment of triterpene aldehyde and glucuronic acid roles in adjuvant function. Vaccine 13: 1403-1410.
-
(1995)
Vaccine
, vol.13
, pp. 1403-1410
-
-
Soltysik, S.1
Wu, J.Y.2
Recchia, J.3
Wheeler, D.A.4
Newman, M.J.5
Coughlin, R.T.6
Kensil, C.R.7
-
14
-
-
0028171987
-
Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma
-
Livingston, P. O. , S. Adluri, F. Helling, T. J. Yao, C. R. Kensil, M. J. Newman, and D. Marciani. 1994. Phase 1 trial of immunological adjuvant QS-21 with a GM2 ganglioside-keyhole limpet haemocyanin conjugate vaccine in patients with malignant melanoma. Vaccine 12: 1275-1280.
-
(1994)
Vaccine
, vol.12
, pp. 1275-1280
-
-
Livingston, P.O.1
Adluri, S.2
Helling, F.3
Yao, T.J.4
Kensil, C.R.5
Newman, M.J.6
Marciani, D.7
-
15
-
-
63149151276
-
ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II
-
Schnurr, M. , M. Orban, N. C. Robson, A. Shin, H. Braley, D. Airey, J. Cebon, E. Maraskovsky, and S. Endres. 2009. ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II. J. Immunol. 182: 1253-1259.
-
(2009)
J. Immunol
, vol.182
, pp. 1253-1259
-
-
Schnurr, M.1
Orban, M.2
Robson, N.C.3
Shin, A.4
Braley, H.5
Airey, D.6
Cebon, J.7
Maraskovsky, E.8
Endres, S.9
-
16
-
-
79960413988
-
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells
-
Duewell, P. , U. Kisser, K. Heckelsmiller, S. Hoves, P. Stoitzner, S. Koernig, A. B. Morelli, B. E. Clausen, M. Dauer, A. Eigler, et al. 2011. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. J. Immunol. 187: 55-63.
-
(2011)
J. Immunol
, Issue.187
, pp. 55-63
-
-
Duewell, P.1
Kisser, U.2
Heckelsmiller, K.3
Hoves, S.4
Stoitzner, P.5
Koernig, S.6
Morelli, A.B.7
Clausen, B.E.8
Dauer, M.9
Eigler, A.10
-
17
-
-
81455154875
-
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children
-
Agnandji, S. T. , B. Lell, S. S. Soulanoudjingar, J. F. Fernandes, B. P. Abossolo, C. Conzelmann, B. G. Methogo, Y. Doucka, A. Flamen, B. Mordm̈uller, et al. 2011. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N. Engl. J. Med. 365: 1863-1875.
-
(2011)
N. Engl. J. Med
, vol.365
, pp. 1863-1875
-
-
Agnandji, S.T.1
Lell, B.2
Soulanoudjingar, S.S.3
Fernandes, J.F.4
Abossolo, B.P.5
Conzelmann, C.6
Methogo, B.G.7
Doucka, Y.8
Flamen, A.9
Mordm̈uller, B.10
-
18
-
-
84871037616
-
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants
-
Agnandji, S. T. , B. Lell, J. F. Fernandes, B. P. Abossolo, B. G. Methogo, A. L. Kabwende, A. A. Adegnika, B. Mordm̈uller, S. Issifou, P. G. Kremsner, et al. 2012. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N. Engl. J. Med. 367: 2284-2295.
-
(2012)
N. Engl. J. Med
, Issue.367
, pp. 2284-2295
-
-
Agnandji, S.T.1
Lell, B.2
Fernandes, J.F.3
Abossolo, B.P.4
Methogo, B.G.5
Kabwende, A.L.6
Adegnika, A.A.7
Mordm̈uller, B.8
Issifou, S.9
Kremsner, P.G.10
-
19
-
-
84859427365
-
Cell-mediated immune responses to a varicella-zoster virus glycoprotein e vaccine using both a TLR agonist and QS21 in mice
-
Dendouga, N. , M. Fochesato, L. Lockman, S. Mossman, and S. L. Giannini. 2012. Cell-mediated immune responses to a varicella-zoster virus glycoprotein E vaccine using both a TLR agonist and QS21 in mice. Vaccine 30: 3126-3135.
-
(2012)
Vaccine
, vol.30
, pp. 3126-3135
-
-
Dendouga, N.1
Fochesato, M.2
Lockman, L.3
Mossman, S.4
Giannini, S.L.5
-
20
-
-
79951823624
-
An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers
-
Van Braeckel, E. , P. Bourguignon, M. Koutsoukos, F. Clement, M. Janssens, I. Carletti, A. Collard, M. A. Demoitié, G. Voss, G. Leroux-Roels, and L. McNally. 2011. An adjuvanted polyprotein HIV-1 vaccine induces polyfunctional cross-reactive CD4+ T cell responses in seronegative volunteers. Clin. Infect. Dis. 52: 522-531.
-
(2011)
Clin. Infect. Dis
, Issue.52
, pp. 522-531
-
-
Van Braeckel, E.1
Bourguignon, P.2
Koutsoukos, M.3
Clement, F.4
Janssens, M.5
Carletti, I.6
Collard, A.7
Demoitié, M.A.8
Voss, G.9
Leroux-Roels, G.10
McNally, L.11
-
21
-
-
77957357557
-
Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems
-
Leroux-Roels, I. , M. Koutsoukos, F. Clement, S. Steyaert, M. Janssens, P. Bourguignon, K. Cohen, M. Altfeld, P. Vandepapelière, L. Pedneault, et al. 2010. Strong and persistent CD4+ T-cell response in healthy adults immunized with a candidate HIV-1 vaccine containing gp120, Nef and Tat antigens formulated in three Adjuvant Systems. Vaccine 28: 7016-7024.
-
(2010)
Vaccine
, vol.28
, pp. 7016-7024
-
-
Leroux-Roels, I.1
Koutsoukos, M.2
Clement, F.3
Steyaert, S.4
Janssens, M.5
Bourguignon, P.6
Cohen, K.7
Altfeld, M.8
Vandepapelière, P.9
Pedneault, L.10
-
22
-
-
84875818500
-
Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
-
Leroux-Roels, I. , S. Forgus, B. F. De, F. Clement, M. A. Demoitie, P. Mettens, P. Moris, E. Ledent, G. Leroux-Roels, and O. Ofori-Anyinam. 2013. Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: a randomized trial. Vaccine 31: 2196-2206.
-
(2013)
Vaccine
, vol.31
, pp. 2196-2206
-
-
Leroux-Roels, I.1
Forgus, S.2
De, B.F.3
Clement, F.4
Demoitie, M.A.5
Mettens, P.6
Moris, P.7
Ledent, E.8
Leroux-Roels, G.9
Ofori-Anyinam, O.10
-
23
-
-
67650699591
-
Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: Safety, efficacy, and immunologic associates of protection
-
Kester, K. E. , J. F. Cummings, O. Ofori-Anyinam, C. F. Ockenhouse, U. Krzych, P. Moris, R. Schwenk, R. A. Nielsen, Z. Debebe, E. Pinelis, et al. 2009. Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection. J. Infect. Dis. 200: 337-346.
-
(2009)
J. Infect. Dis
, vol.200
, pp. 337-346
-
-
Kester, K.E.1
Cummings, J.F.2
Ofori-Anyinam, O.3
Ockenhouse, C.F.4
Krzych, U.5
Moris, P.6
Schwenk, R.7
Nielsen, R.A.8
Debebe, Z.9
Pinelis, E.10
-
24
-
-
84871666296
-
A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E
-
Ndungu, F. M. , J. Mwacharo, D. Kimani, O. Kai, P. Moris, E. Jongert, J. Vekemans, A. Olotu, and P. Bejon. 2012. A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E. PLoS One 7: e52870.
-
(2012)
PLoS One
, vol.7
-
-
Ndungu, F.M.1
Mwacharo, J.2
Kimani, D.3
Kai, O.4
Moris, P.5
Jongert, E.6
Vekemans, J.7
Olotu, A.8
Bejon, P.9
-
25
-
-
80053602298
-
Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria
-
Olotu, A. , P. Moris, J. Mwacharo, J. Vekemans, D. Kimani, M. Janssens, O. Kai, E. Jongert, M. Lievens, A. Leach, et al. 2011. Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria. PLoS One 6: e25786.
-
(2011)
PLoS One
, vol.6
-
-
Olotu, A.1
Moris, P.2
Mwacharo, J.3
Vekemans, J.4
Kimani, D.5
Janssens, M.6
Kai, O.7
Jongert, E.8
Lievens, M.9
Leach, A.10
-
26
-
-
84875133333
-
Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure
-
Olotu, A. , G. Fegan, J. Wambua, G. Nyangweso, K. O. Awuondo, A. Leach, M. Lievens, D. Leboulleux, P. Njuguna, N. Peshu, et al. 2013. Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure. N. Engl. J. Med. 368: 1111-1120.
-
(2013)
N. Engl. J. Med
, Issue.368
, pp. 1111-1120
-
-
Olotu, A.1
Fegan, G.2
Wambua, J.3
Nyangweso, G.4
Awuondo, K.O.5
Leach, A.6
Lievens, M.7
Leboulleux, D.8
Njuguna, P.9
Peshu, N.10
-
27
-
-
68149092706
-
Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area
-
Polhemus, M. E. , S. A. Remich, B. R. Ogutu, J. N. Waitumbi, L. Otieno, S. Apollo, J. F. Cummings, K. E. Kester, C. F. Ockenhouse, A. Stewart, et al. 2009. Evaluation of RTS,S/AS02A and RTS,S/AS01B in adults in a high malaria transmission area. PLoS ONE 4: e6465.
-
(2009)
PLoS ONE
, vol.4
-
-
Polhemus, M.E.1
Remich, S.A.2
Ogutu, B.R.3
Waitumbi, J.N.4
Otieno, L.5
Apollo, S.6
Cummings, J.F.7
Kester, K.E.8
Ockenhouse, C.F.9
Stewart, A.10
-
28
-
-
18644375874
-
In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens
-
Jung, S. , D. Unutmaz, P. Wong, G. Sano, K. De los Santos, T. Sparwasser, S. Wu, S. Vuthoori, K. Ko, F. Zavala, et al. 2002. In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens. Immunity 17: 211-220.
-
(2002)
Immunity
, vol.17
, pp. 211-220
-
-
Jung, S.1
Unutmaz, D.2
Wong, P.3
Sano, G.4
De Los Santos, K.5
Sparwasser, T.6
Wu, S.7
Vuthoori, S.8
Ko, K.9
Zavala, F.10
-
29
-
-
84856826706
-
CD64 expression distinguishes monocytederived and conventional dendritic cells and reveals their distinct role during intramuscular immunization
-
Langlet, C. , S. Tamoutounour, S. Henri, H. Luche, L. Ardouin, C. Grégoire, B. Malissen, and M. Guilliams. 2012. CD64 expression distinguishes monocytederived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. J. Immunol. 188: 1751-1760.
-
(2012)
J. Immunol
, Issue.188
, pp. 1751-1760
-
-
Langlet, C.1
Tamoutounour, S.2
Henri, S.3
Luche, H.4
Ardouin, L.5
Grégoire, C.6
Malissen, B.7
Guilliams, M.8
-
30
-
-
79952362612
-
Adjuvant System AS03 containing a-tocopherol modulates innate immune response and leads to improved adaptive immunity
-
Morel, S. , A. Didierlaurent, P. Bourguignon, S. Delhaye, B. Baras, V. Jacob, C. Planty, A. Elouahabi, P. Harvengt, H. Carlsen, et al. 2011. Adjuvant System AS03 containing a-tocopherol modulates innate immune response and leads to improved adaptive immunity. Vaccine 29: 2461-2473.
-
(2011)
Vaccine
, vol.29
, pp. 2461-2473
-
-
Morel, S.1
Didierlaurent, A.2
Bourguignon, P.3
Delhaye, S.4
Baras, B.5
Jacob, V.6
Planty, C.7
Elouahabi, A.8
Harvengt, P.9
Carlsen, H.10
-
31
-
-
77956132142
-
From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets
-
Guilliams, M. , S. Henri, S. Tamoutounour, L. Ardouin, I. Schwartz-Cornil, M. Dalod, and B. Malissen. 2010. From skin dendritic cells to a simplified classification of human and mouse dendritic cell subsets. Eur. J. Immunol. 40: 2089-2094.
-
(2010)
Eur. J. Immunol
, Issue.40
, pp. 2089-2094
-
-
Guilliams, M.1
Henri, S.2
Tamoutounour, S.3
Ardouin, L.4
Schwartz-Cornil, I.5
Dalod, M.6
Malissen, B.7
-
32
-
-
67649404131
-
Blood monocytes: Development, heterogeneity, and relationship with dendritic cells
-
Auffray, C. , M. H. Sieweke, and F. Geissmann. 2009. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu. Rev. Immunol. 27: 669-692.
-
(2009)
Annu. Rev. Immunol
, vol.27
, pp. 669-692
-
-
Auffray, C.1
Sieweke, M.H.2
Geissmann, F.3
-
33
-
-
84893657950
-
The function of Fcg receptors in dendritic cells and macrophages
-
Guilliams, M. , P. Bruhns, Y. Saeys, H. Hammad, and B. N. Lambrecht. 2014. The function of Fcg receptors in dendritic cells and macrophages. Nat. Rev. Immunol. 14: 94-108.
-
(2014)
Nat. Rev. Immunol
, Issue.14
, pp. 94-108
-
-
Guilliams, M.1
Bruhns, P.2
Saeys, Y.3
Hammad, H.4
Lambrecht, B.N.5
-
34
-
-
84869395522
-
Re(de)fining the dendritic cell lineage
-
Satpathy, A. T. , X. Wu, J. C. Albring, and K. M. Murphy. 2012. Re(de)fining the dendritic cell lineage. Nat. Immunol. 13: 1145-1154.
-
(2012)
Nat. Immunol
, vol.13
, pp. 1145-1154
-
-
Satpathy, A.T.1
Wu, X.2
Albring, J.C.3
Murphy, K.M.4
-
35
-
-
84861661926
-
ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway
-
Wilson, N. S. , B. Yang, A. B. Morelli, S. Koernig, A. Yang, S. Loeser, D. Airey, L. Provan, P. Hass, H. Braley, et al. 2012. ISCOMATRIX vaccines mediate CD8+ T-cell cross-priming by a MyD88-dependent signaling pathway. Immunol. Cell Biol. 90: 540-552.
-
(2012)
Immunol. Cell Biol
, Issue.90
, pp. 540-552
-
-
Wilson, N.S.1
Yang, B.2
Morelli, A.B.3
Koernig, S.4
Yang, A.5
Loeser, S.6
Airey, D.7
Provan, L.8
Hass, P.9
Braley, H.10
-
36
-
-
77958111199
-
Dynamics of dendritic cell?T cell interactions: A role in T cell outcome
-
Hugues, S. 2010. Dynamics of dendritic cell?T cell interactions: a role in T cell outcome. Semin. Immunopathol. 32: 227-238.
-
(2010)
Semin. Immunopathol
, Issue.32
, pp. 227-238
-
-
Hugues, S.1
-
37
-
-
19344376093
-
Antigen persistence is required throughout the expansion phase of a CD4+ T cell response
-
Obst, R. , H. M. van Santen, D. Mathis, and C. Benoist. 2005. Antigen persistence is required throughout the expansion phase of a CD4+ T cell response. J. Exp. Med. 201: 1555-1565.
-
(2005)
J. Exp. Med
, vol.201
, pp. 1555-1565
-
-
Obst, R.1
Van Santen, H.M.2
Mathis, D.3
Benoist, C.4
-
38
-
-
84861963478
-
The mechanism of action of MF59-an innately attractive adjuvant formulation
-
O'Hagan, D. T. , G. S. Ott, E. De Gregorio, and A. Seubert. 2012. The mechanism of action of MF59-an innately attractive adjuvant formulation. Vaccine 30: 4341-4348.
-
(2012)
Vaccine
, vol.30
, pp. 4341-4348
-
-
O'Hagan, D.T.1
Ott, G.S.2
De Gregorio, E.3
Seubert, A.4
-
39
-
-
56149119563
-
Cutting edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome
-
Kool, M. , V. Pétrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I. M. Bergen, R. Castillo, B. N. Lambrecht, and J. Tschopp. 2008. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181: 3755-3759.
-
(2008)
J. Immunol
, vol.181
, pp. 3755-3759
-
-
Kool, M.1
Pétrilli, V.2
De Smedt, T.3
Rolaz, A.4
Hammad, H.5
Van Nimwegen, M.6
Bergen, I.M.7
Castillo, R.8
Lambrecht, B.N.9
Tschopp, J.10
-
40
-
-
84861138889
-
Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses
-
Kamath, A. T. , B. Mastelic, D. Christensen, A. F. Rochat, E. M. Agger, D. D. Pinschewer, P. Andersen, P. H. Lambert, and C. A. Siegrist. 2012. Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses. J. Immunol. 188: 4828-4837.
-
(2012)
J. Immunol
, Issue.188
, pp. 4828-4837
-
-
Kamath, A.T.1
Mastelic, B.2
Christensen, D.3
Rochat, A.F.4
Agger, E.M.5
Pinschewer, D.D.6
Andersen, P.7
Lambert, P.H.8
Siegrist, C.A.9
-
41
-
-
28044432553
-
Innate control of adaptive immunity via remodeling of lymph node feed arteriole
-
Soderberg, K. A. , G. W. Payne, A. Sato, R. Medzhitov, S. S. Segal, and A. Iwasaki. 2005. Innate control of adaptive immunity via remodeling of lymph node feed arteriole. Proc. Natl. Acad. Sci. USA 102: 16315-16320.
-
(2005)
Proc. Natl. Acad. Sci. USA
, vol.102
, pp. 16315-16320
-
-
Soderberg, K.A.1
Payne, G.W.2
Sato, A.3
Medzhitov, R.4
Segal, S.S.5
Iwasaki, A.6
-
42
-
-
84867900263
-
HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes
-
Girard, J. P. , C. Moussion, and R. Förster. 2012. HEVs, lymphatics and homeostatic immune cell trafficking in lymph nodes. Nat. Rev. Immunol. 12: 762-773.
-
(2012)
Nat. Rev. Immunol
, Issue.12
, pp. 762-773
-
-
Girard, J.P.1
Moussion, C.2
Förster, R.3
-
43
-
-
0036681837
-
The CXC chemokine murine monokine induced by IFN-g (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo
-
Park, M. K. , D. Amichay, P. Love, E. Wick, F. Liao, A. Grinberg, R. L. Rabin, H. H. Zhang, S. Gebeyehu, T. M. Wright, et al. 2002. The CXC chemokine murine monokine induced by IFN-g (CXC chemokine ligand 9) is made by APCs, targets lymphocytes including activated B cells, and supports antibody responses to a bacterial pathogen in vivo. J. Immunol. 169: 1433-1443.
-
(2002)
J. Immunol
, vol.169
, pp. 1433-1443
-
-
Park, M.K.1
Amichay, D.2
Love, P.3
Wick, E.4
Liao, F.5
Grinberg, A.6
Rabin, R.L.7
Zhang, H.H.8
Gebeyehu, S.9
Wright, T.M.10
-
44
-
-
84870864876
-
CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation
-
Groom, J. R. , J. Richmond, T. T. Murooka, E. W. Sorensen, J. H. Sung, K. Bankert, U. H. von Andrian, J. J. Moon, T. R. Mempel, and A. D. Luster. 2012. CXCR3 chemokine receptor-ligand interactions in the lymph node optimize CD4+ T helper 1 cell differentiation. Immunity 37: 1091-1103.
-
(2012)
Immunity
, vol.37
, pp. 1091-1103
-
-
Groom, J.R.1
Richmond, J.2
Murooka, T.T.3
Sorensen, E.W.4
Sung, J.H.5
Bankert, K.6
Von Andrian, U.H.7
Moon, J.J.8
Mempel, T.R.9
Luster, A.D.10
-
45
-
-
78049413094
-
Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants
-
Yang, C. W. , B. S. Strong, M. J. Miller, and E. R. Unanue. 2010. Neutrophils influence the level of antigen presentation during the immune response to protein antigens in adjuvants. J. Immunol. 185: 2927-2934.
-
(2010)
J. Immunol
, Issue.185
, pp. 2927-2934
-
-
Yang, C.W.1
Strong, B.S.2
Miller, M.J.3
Unanue, E.R.4
-
46
-
-
79952704589
-
Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
-
Calabro, S. , M. Tortoli, B. C. Baudner, A. Pacitto, M. Cortese, D. T. O'Hagan, E. De Gregorio, A. Seubert, and A. Wack. 2011. Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes. Vaccine 29: 1812-1823.
-
(2011)
Vaccine
, vol.29
, pp. 1812-1823
-
-
Calabro, S.1
Tortoli, M.2
Baudner, B.C.3
Pacitto, A.4
Cortese, M.5
O'Hagan, D.T.6
De Gregorio, E.7
Seubert, A.8
Wack, A.9
-
47
-
-
79960829290
-
Neutrophils in the activation and regulation of innate and adaptive immunity
-
Mantovani, A. , M. A. Cassatella, C. Costantini, and S. Jaillon. 2011. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat. Rev. Immunol. 11: 519-531.
-
(2011)
Nat. Rev. Immunol
, Issue.11
, pp. 519-531
-
-
Mantovani, A.1
Cassatella, M.A.2
Costantini, C.3
Jaillon, S.4
-
48
-
-
34248997759
-
Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis
-
Arnold, L. , A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
-
(2007)
J. Exp. Med
, vol.204
, pp. 1057-1069
-
-
Arnold, L.1
Henry, A.2
Poron, F.3
Baba-Amer, Y.4
Van Rooijen, N.5
Plonquet, A.6
Gherardi, R.K.7
Chazaud, B.8
-
49
-
-
77349089236
-
Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation
-
Domínguez, P. M. , and C. Ardavín. 2010. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation. Immunol. Rev. 234: 90-104.
-
(2010)
Immunol. Rev
, Issue.234
, pp. 90-104
-
-
Domínguez, P.M.1
Ardavín, C.2
-
50
-
-
62849119018
-
Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses
-
Nakano, H. , K. L. Lin, M. Yanagita, C. Charbonneau, D. N. Cook, T. Kakiuchi, and M. D. Gunn. 2009. Blood-derived inflammatory dendritic cells in lymph nodes stimulate acute T helper type 1 immune responses. Nat. Immunol. 10: 394-402.
-
(2009)
Nat. Immunol
, vol.10
, pp. 394-402
-
-
Nakano, H.1
Lin, K.L.2
Yanagita, M.3
Charbonneau, C.4
Cook, D.N.5
Kakiuchi, T.6
Gunn, M.D.7
-
51
-
-
80052173363
-
T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella
-
Flores-Langarica, A. , J. L. Marshall, S. Bobat, E. Mohr, J. Hitchcock, E. A. Ross, R. E. Coughlan, M. Khan, N. Van Rooijen, I. R. Henderson, et al. 2011. T-zone localized monocyte-derived dendritic cells promote Th1 priming to Salmonella. Eur. J. Immunol. 41: 2654-2665.
-
(2011)
Eur. J. Immunol
, Issue.41
, pp. 2654-2665
-
-
Flores-Langarica, A.1
Marshall, J.L.2
Bobat, S.3
Mohr, E.4
Hitchcock, J.5
Ross, E.A.6
Coughlan, R.E.7
Khan, M.8
Van Rooijen, N.9
Henderson, I.R.10
-
52
-
-
84866489404
-
Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion
-
Soudja, S. M. , A. L. Ruiz, J. C. Marie, and G. Lauvau. 2012. Inflammatory monocytes activate memory CD8+ T and innate NK lymphocytes independent of cognate antigen during microbial pathogen invasion. Immunity 37: 549-562
-
(2012)
Immunity
, vol.37
, pp. 549-562
-
-
Soudja, S.M.1
Ruiz, A.L.2
Marie, J.C.3
Lauvau, G.4
-
53
-
-
84871109342
-
Suppression of vaccine immunity by inflammatory monocytes
-
Mitchell, L. A. , A. J. Henderson, and S. W. Dow. 2012. Suppression of vaccine immunity by inflammatory monocytes. J. Immunol. 189: 5612-5621.
-
(2012)
J. Immunol
, Issue.189
, pp. 5612-5621
-
-
Mitchell, L.A.1
Henderson, A.J.2
Dow, S.W.3
-
54
-
-
47849087075
-
Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3
-
Li, H. , S. B. Willingham, J. P. Ting, and F. Re. 2008. Cutting edge: inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J. Immunol. 181: 17-21.
-
(2008)
J. Immunol
, vol.181
, pp. 17-21
-
-
Li, H.1
Willingham, S.B.2
Ting, J.P.3
Re, F.4
-
55
-
-
39249083535
-
Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers
-
Vandepapelière, P. , Y. Horsmans, P. Moris, M. Van Mechelen, M. Janssens, M. Koutsoukos, P. Van Belle, F. Clement, E. Hanon, M. Wettendorff, et al. 2008. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers. Vaccine 26: 1375-1386.
-
(2008)
Vaccine
, vol.26
, pp. 1375-1386
-
-
Vandepapelière, P.1
Horsmans, Y.2
Moris, P.3
Van Mechelen, M.4
Janssens, M.5
Koutsoukos, M.6
Van Belle, P.7
Clement, F.8
Hanon, E.9
Wettendorff, M.10
|